Position in HLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$496,115
New position
Shares Held
49,562
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Quadrature Capital Ltd holds $19,705,818 across 19 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
84,526 | $9,991,818 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,544 | $2,101,521 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,683 | $1,802,598 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
147,314 | $795,495 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,768 | $754,928 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
30,561 | $598,689 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
11,501 | $594,486 | |
| 8 | HLN |
Haleon plc
This page
|
49,562 | $496,115 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $496,115 | 49,562 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||